The investigation of efficacy and safety about the clinical pathway for congestive heart failure specified immediate use of tolvaptan after admission in super-elderly patients.
27 May 2019 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
Mitoyo General Hospital, Kagawa (Japan)
56 More presentations in this session
Access the full session
The Event
Heart Failure 2019
27 May 2019
08:30 CET
